Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents

被引:14
作者
Hosseini, Maryam
Miri, Ramin [1 ]
Amini, Mohsen
Mirkhani, Hossein
Hemmateenejad, Bahram
Ghodsi, Shahrarn
Alipour, Eskandar
Shaflee, Abbas
机构
[1] Islamic Azad Univ, Fac Chem, N Tehran Branch, Tehran, Iran
[2] Univ Teheran Med Sci, Fac Pharm, Dept Med Chem, Tehran, Iran
[3] Univ Teheran Med Sci, Pharmaceut Sci Res Ctr, Tehran, Iran
[4] Shiraz Univ Med Sci, Med & Nat Products Chem Res Ctr, Shiraz, Iran
[5] Shiraz Univ, Dept Chem, Shiraz, Iran
[6] Islamic Azad Univ, Dept Chem, Karaj Branch, Karaj, Iran
关键词
calcium antagonist; dichloroimiclazole; dihydropyridine; OSAR analysis;
D O I
10.1002/ardp.200600211
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A group of dialkyl and diarylester analogues of nifedipine, in which the ortho-nitrophenyl group at position 4 was replaced by a 1-methyl-4,5-dichloroimidazolyl substituent, were synthesized and evaluated as calcium-channel antagonists using the high K, concentration of guinea-pig ileum longitudinal smooth muscle. The structure of all compounds was confirmed by IR, (HNMR)-H-1, and mass spectra. The calcium-channel antagonist activity of compounds 10a-f demonstrated that compound 10b was the most active and 10f the least active one. With unsymmetrical diesters 12a-k, the most active compound was the ethyl, phenethyl derivative. Structural parameters on the calcium-channel antagonist activity were evaluated by QSAR analysis and a linear correlation was found between the -log IC50 values of these compounds and their constitutional and topological properties.
引用
收藏
页码:549 / 556
页数:8
相关论文
共 23 条
[1]   SYNTHESIS AND CALCIUM-CHANNEL ANTAGONIST ACTIVITY OF 3-ARYLMETHYL 5-ISOPROPYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(PYRIDYL)-3,5-PYRIDINEDICARBOXYLATES [J].
AKULA, MR ;
MATOWE, WC ;
WOLOWYK, MW ;
KNAUS, EE .
PHARMACEUTICAL RESEARCH, 1990, 7 (09) :919-922
[2]  
Amini M, 2002, ARZNEIMITTEL-FORSCH, V52, P21
[3]   LONG-ACTING DIHYDROPYRIDINE CALCIUM-ANTAGONISTS .1. 2-ALKOXYMETHYL DERIVATIVES INCORPORATING BASIC SUBSTITUENTS [J].
ARROWSMITH, JE ;
CAMPBELL, SF ;
CROSS, PE ;
STUBBS, JK ;
BURGES, RA ;
GARDINER, DG ;
BLACKBURN, KJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (09) :1696-1702
[4]   DIKETENE [J].
CLEMENS, RJ .
CHEMICAL REVIEWS, 1986, 86 (02) :241-318
[5]   Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5(4)-imidazolyl substituent [J].
Davood, Asghar ;
Mansouri, Niloufar ;
Dehpour, Ahmad Rerza ;
Shafaroudi, Harried ;
Ali-Pour, Eskandar ;
Shafiee, Abbas .
ARCHIV DER PHARMAZIE, 2006, 339 (06) :299-304
[6]   SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE [J].
FLECKENSTEIN, A .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 :149-166
[7]   1,4-DIHYDROPYRIDINES - EFFECTS OF CHIRALITY AND CONFORMATION ON THE CALCIUM-ANTAGONIST AND CALCIUM AGONIST ACTIVITIES [J].
GOLDMANN, S ;
STOLTEFUSS, J .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1991, 30 (12) :1559-1578
[8]  
Hantzsch A., 1882, LIEBIGS ANN CHEM, V215, P1, DOI [10.1002/jlac.18822150102, DOI 10.1002/JLAC.18822150102]
[9]   Conformational analysis of some new derivatives of 4-nitroimidazolyl-1,4-dihydropyridine-based calcium channel blockers [J].
Hemmateenejad, B ;
Miri, R ;
Safarpour, MA ;
Khoshneviszadeh, M ;
Edraki, N .
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2005, 717 (1-3) :139-152
[10]   Application of ab initio theory to QSAR study of 1,4-dihydropyridine-based calcium channel blockers using GA-MLR and PC-GA-ANN procedures [J].
Hemmateenejad, B ;
Safarpour, MA ;
Miri, R ;
Taghavi, F .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (12) :1495-1503